Moody's
MCO
Coca-Cola
KO
VeriSign
VRSN
MasterCard
MA
DaVita
DVA
US Stock MarketDetailed Quotes
SYRE Spyre Therapeutics
- 24.020
- -0.330-1.36%
Close Jan 8 16:00 ET
- 24.020
- 0.0000.00%
Post 20:01 ET
1.41BMarket Cap-16.01P/E (TTM)
24.520High23.770Low484.64KVolume24.210Open24.350Pre Close11.66MTurnover1.06%Turnover RatioLossP/E (Static)58.67MShares47.97052wk High8.21P/B1.10BFloat Cap20.07052wk Low--Dividend TTM45.73MShs Float318.750Historical High--Div YieldTTM3.08%Amplitude2.650Historical Low24.061Avg Price1Lot Size
Spyre Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | -61.96%886K | 0 | 0 | 10.08%688K | -85.46%198K | -87.57%2.33M | -95.39%168K |
| Operating revenue | --0 | --0 | --0 | -61.96%886K | --0 | --0 | 10.08%688K | -85.46%198K | -87.57%2.33M | -95.39%168K |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 66.62%55.39M | 49.92%44.15M | 151.39%47.77M | 48.61%129.45M | 147.05%47.75M | 75.62%33.24M | 27.77%29.45M | -26.35%19M | 3.23%87.11M | -19.75%19.33M |
| Selling and administrative expenses | 24.04%10.65M | -4.57%11.51M | 145.72%12.85M | 40.01%39.95M | 177.06%14.07M | 23.48%8.58M | 57.16%12.06M | -40.76%5.23M | 4.44%28.53M | -30.46%5.08M |
| -General and administrative expense | 24.04%10.65M | -4.57%11.51M | 145.72%12.85M | 40.01%39.95M | 177.06%14.07M | 23.48%8.58M | 57.16%12.06M | -40.76%5.23M | 4.44%28.53M | -30.46%5.08M |
| Research and development costs | 81.44%44.74M | 87.71%32.64M | 153.54%34.93M | 52.79%89.5M | 136.35%33.68M | 105.89%24.66M | 13.09%17.39M | -18.86%13.78M | 2.65%58.58M | -15.08%14.25M |
| Operating profit | -66.62%-55.39M | -53.50%-44.15M | -154.04%-47.77M | -51.64%-128.56M | -149.21%-47.75M | -77.25%-33.24M | -28.26%-28.76M | 23.06%-18.81M | -29.14%-84.78M | 6.26%-19.16M |
| Net non-operating interest income expense | 314.39%5.18M | 1,591.43%5.92M | 955.24%4.43M | 634.41%6.15M | 906.34%4.13M | 334.38%1.25M | 236.54%350K | 1,100.00%420K | 654.05%837K | 1,105.88%410K |
| Non-operating interest income | 314.39%5.18M | 1,591.43%5.92M | 955.24%4.43M | 634.41%6.15M | 906.34%4.13M | 334.38%1.25M | 236.54%350K | 1,100.00%420K | 654.05%837K | 1,105.88%410K |
| Other net income (expense) | -131.81%-18.8M | 99.68%-610K | -570.83%-483K | -3,091,314.29%-216.4M | -61,000.00%-19.55M | -33,895.83%-8.11M | -3,773,380.00%-188.66M | -140.00%-72K | 94.26%-7K | -113.33%-32K |
| Gain on sale of security | ---- | ---- | ---- | ---83.53M | --0 | ---25.36M | ---58.17M | ---- | ---- | ---- |
| Special income (charges) | --0 | --0 | ---- | ---113.74M | --1.84M | --14.91M | ---130.49M | ---- | --0 | --0 |
| -Less:Other special charges | ---- | ---- | ---- | --130.19M | --0 | ---298K | --130.49M | ---- | ---- | ---- |
| -Gain on sale of property,plant,equipment | --0 | ---- | ---- | --16.45M | --1.84M | --14.61M | ---- | ---- | --0 | --0 |
| Other non- operating income (expenses) | -902.82%-18.8M | -7,525.00%-610K | -570.83%-483K | -273,185.71%-19.13M | -66,750.00%-21.39M | 9,658.33%2.34M | -260.00%-8K | -140.00%-72K | 94.26%-7K | -113.33%-32K |
| Income before tax | -72.08%-69.01M | 82.11%-38.84M | -137.43%-43.83M | -303.59%-338.82M | -236.35%-63.18M | -117.45%-40.1M | -872.82%-217.07M | 24.46%-18.46M | -27.86%-83.95M | 8.03%-18.78M |
| Income tax | 500.00%18K | 0 | 188.89%32K | 80.88%-26K | 0 | 101.44%3K | -22.22%7K | -36K | -196.45%-136K | 65.22%38K |
| Net income | -72.11%-69.03M | 82.11%-38.84M | -138.07%-43.86M | -304.21%-338.79M | -235.67%-63.18M | -119.96%-40.11M | -872.45%-217.08M | 24.61%-18.42M | -27.38%-83.82M | 7.94%-18.82M |
| Net income continuous Operations | -72.11%-69.03M | 82.11%-38.84M | -138.07%-43.86M | -304.21%-338.79M | -235.67%-63.18M | -119.96%-40.11M | -872.45%-217.08M | 24.61%-18.42M | -27.38%-83.82M | 7.94%-18.82M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -72.11%-69.03M | 82.11%-38.84M | -138.07%-43.86M | -304.21%-338.79M | -235.67%-63.18M | -119.96%-40.11M | -872.45%-217.08M | 24.61%-18.42M | -27.38%-83.82M | 7.94%-18.82M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -72.11%-69.03M | 82.11%-38.84M | -138.07%-43.86M | -304.21%-338.79M | -235.67%-63.18M | -119.96%-40.11M | -872.45%-217.08M | 24.61%-18.42M | -27.38%-83.82M | 7.94%-18.82M |
| Basic earnings per share | -23.26%-1.06 | 98.53%-0.59 | 85.28%-0.72 | 44.65%-13.76 | 62.64%-1.7522 | 82.23%-0.86 | -494.67%-40.14 | 47.14%-4.89 | 0.64%-24.86 | 39.64%-4.69 |
| Diluted earnings per share | -23.26%-1.06 | 98.53%-0.59 | 85.28%-0.72 | 44.65%-13.76 | 62.64%-1.7522 | 82.23%-0.86 | -494.67%-40.14 | 47.14%-4.89 | 0.64%-24.86 | 39.64%-4.69 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
Trending US Stocks
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.